Blog
Featured
For patients with heart disease, getting on the right medicine quickly can mean the difference between a fatal cardiac event and another day doing what they love.
In a big win for heart patients, national guidelines to treat hypertrophic cardiomyopathy now include the first-of-its-kind medication – cardiac myosin inhibitors – as a first-line treatment.
Game-changing medical technology is on the line.
Based on Nobel-prize winning science, genetically targeted technologies take on the proteins that cause disease. The medications are administered once or twice a year to treat rare and debilitating diseases, from Duchenne muscular dystrophy to high cholesterol.
Lower out-of-pocket prescription drugs costs spread more manageably across the calendar year. That’s what patients and policymakers alike hope to get from the Inflation Reduction Act.
Finding the right medication for a heart condition can be tricky and time consuming. So what happens when the insurance company then compels patients to switch?
Despite the range of existing treatment options, hypertension bears a growing burden on Americans and requires innovative solutions. A new policy paper from the Partnership to Advance Cardiovascular Health, “Pressure’s Mounting,” hears cardiologists, nurses and patient advocates describe the widespread disease’s impact and the importance of individualized treatment.
This year’s national Cardiovascular Health Policy Summit brought together patient advocates, health care providers and policy experts to discuss solutions to barriers that keep cardiovascular patients from accessing the care they need.
For some people, the first “symptom” of hypertension is a deadly heart attack or stroke.
Cardiovascular disease stubbornly holds its place as the number one cause of death in America. But don’t be misled into thinking heart disease presents an equitable burden. It has a disproportionately high impact on Black Americans, striking them more often and more seriously, on average, than their white counterparts.
Yet another study has found that high co-pays could restrict cardiovascular disease patients’ access to prescription drugs.
Peripheral artery disease, known as PAD, can cause serious health consequences. If left untreated, it can lead to a heart attack, a stroke or even amputation.
In the United States, cardiovascular disease is a leading cause of death for both men and women. Cardiovascular diseases can manifest through a number of disorders of the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and deep vein thrombosis.
The Partnership to Advance Cardiovascular Health brought together patient advocates, health care providers and policy experts to discuss solutions to overcome the hurdles that keep cardiovascular patients from accessing the most appropriate care.
Things are looking up for patients who have an uncommon heart condition. The Food and Drug Administration last month approved a novel medication to treat obstructive hypertrophic cardiomyopathy.
“A few of my patients are kids. Others are over age 90. But nearly all are overweight or obese.”
As an aging America faces rising rates of obesity and diabetes, people may also find themselves facing a dangerous cardiovascular disease.
Millions of people susceptible to blood clots started 2022 at higher risk of stroke. Why? Their health plan’s pharmacy benefit manager decided to stop covering their blood thinner.
The pandemic pushed the nation’s health care system to the brink. Hospitals even turned patients away during surges. It’s a terrible scenario. And it should be a wake-up call.
Every new COVID-19 variant reignites fears of untimely deaths. Yet heart disease continues to kill more people than the coronavirus every single year.
As a cardiologist, I see health care as more than a political issue. It’s been central to my life for three decades.
What if we – as a health care community – focused on cardiovascular disease prevention with the same level of intensity as we do treatment?
One day, when my son Dean was just seven weeks old, his grandma was over for a visit. She held him as we chatted, but I had a hard time following the conversation. I was noticing that Dean’s head was bobbing unnaturally, and I heard an unusual grunting sound as he labored to breathe.
A new treatment approach may allow patients to manage AFib more effectively.
Cardiovascular disease reigns supreme as America’s top killer, claiming 655,000 lives each year. But instead of prioritizing care for heart conditions, health plans regularly switch up patients’ medications in an attempt to boost profits.
America faces a good news-bad news situation, according to the newly published annual report from the American Cancer Society.
Californians in danger of a heart attack or stroke now have help reducing a key risk factor.
From fat shaming to self-love, America’s debate over weight often overlooks a critical point. Obesity is a dangerous and chronic health condition that drives both cardiovascular disease and Type 2 diabetes.
It can take 17 years for medical breakthroughs to move from the lab to the clinic, where patients can finally benefit. Why the lag?
By Dan LoDolce
I had been experiencing chest pain for a while. It was robbing me of joy – and it was often embarrassing. I’d begun to dread going to the Dodgers’ games with my friends because there were so many stairs. Once, during a work trip to San Francisco, I couldn’t keep pace with my boss and other colleagues as we walked around the hilly city.
Heart disease and Type 2 diabetes aren’t just common. They commonly occur together. So why does the health care system force patients with both conditions to treat one disease at a time?